Leyre Urigüen

1.4k total citations
42 papers, 996 citations indexed

About

Leyre Urigüen is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Leyre Urigüen has authored 42 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 17 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Leyre Urigüen's work include Cannabis and Cannabinoid Research (16 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (11 papers). Leyre Urigüen is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (11 papers). Leyre Urigüen collaborates with scholars based in Spain, Colombia and Belgium. Leyre Urigüen's co-authors include Jorge Manzanares, Sandra Pérez-Rial, J. Javier Meana, Tomás Palomo, Luís F. Callado, Catherine Ledent, Inés Ibarra‐Lecue, Rebeca Dı́ez-Alarcia, Enrique Hilario and Miren Revuelta and has published in prestigious journals such as PLoS ONE, Neuropsychopharmacology and Biochemical Pharmacology.

In The Last Decade

Leyre Urigüen

39 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leyre Urigüen Spain	18	572	554	195	112	108	42	996
Francisco Alén Spain	21	298 0.5×	401 0.7×	256 1.3×	143 1.3×	195 1.8×	47	1.1k
Silvana Gaetani Italy	12	277 0.5×	370 0.7×	104 0.5×	72 0.6×	141 1.3×	13	682
Samira G. Ferreira Portugal	16	386 0.7×	326 0.6×	162 0.8×	104 0.9×	100 0.9×	33	829
Brian C. Shonesy United States	17	564 1.0×	413 0.7×	296 1.5×	55 0.5×	182 1.7×	20	1.0k
Carmen Mazzola Italy	14	608 1.1×	456 0.8×	315 1.6×	70 0.6×	144 1.3×	19	1.0k
Laura Jiménez-Sánchez Spain	13	426 0.7×	433 0.8×	139 0.7×	158 1.4×	44 0.4×	22	868
Amanda J. Sales Brazil	15	310 0.5×	513 0.9×	233 1.2×	217 1.9×	75 0.7×	27	920
Serena Deiana Germany	15	836 1.5×	903 1.6×	241 1.2×	47 0.4×	182 1.7×	24	1.4k
Adena S. Spiro Australia	12	305 0.5×	379 0.7×	173 0.9×	34 0.3×	126 1.2×	12	871
Sharon Goodenough Germany	13	865 1.5×	886 1.6×	324 1.7×	69 0.6×	183 1.7×	16	1.6k

Countries citing papers authored by Leyre Urigüen

Since Specialization

Citations

This map shows the geographic impact of Leyre Urigüen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyre Urigüen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyre Urigüen more than expected).

Fields of papers citing papers by Leyre Urigüen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyre Urigüen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyre Urigüen. The network helps show where Leyre Urigüen may publish in the future.

Co-authorship network of co-authors of Leyre Urigüen

This figure shows the co-authorship network connecting the top 25 collaborators of Leyre Urigüen. A scholar is included among the top collaborators of Leyre Urigüen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyre Urigüen. Leyre Urigüen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horrillo, Igor, Rafael Segarra, J. Javier Meana, et al.. (2025). Extracellular matrix dysfunction and synaptic alterations in schizophrenia. Molecular Psychiatry. 31(1). 396–406. 1 indexed citations

Vicente, Maria Adrielle, et al.. (2025). Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. Pharmaceuticals. 18(12). 1817–1817.

Moreno, Estefanía, Rebeca Dı́ez-Alarcia, Cristina Blázquez, et al.. (2024). The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls. EMBO Molecular Medicine. 16(4). 755–783. 2 indexed citations

Moreno, Estefanía, Rebeca Dı́ez-Alarcia, Ángeles Canales, et al.. (2023). Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43. Neuropharmacology. 240. 109712–109712.

Urigüen, Leyre, et al.. (2023). Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response. Methods in molecular biology. 2687. 57–64. 1 indexed citations

Ibarra‐Lecue, Inés, Igor Horrillo, J. Javier Meana, et al.. (2022). Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction Biology. 27(6). e13233–e13233. 11 indexed citations

Ibarra‐Lecue, Inés, Rebeca Dı́ez-Alarcia, Benito Morentín, et al.. (2020). Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia. Frontiers in Pharmacology. 11. 344–344. 23 indexed citations

Horrillo, Igor, Jorge E. Ortega, Rebeca Dı́ez-Alarcia, Leyre Urigüen, & J. Javier Meana. (2019). Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus. Neuropharmacology. 158. 107731–107731. 6 indexed citations

Ibarra‐Lecue, Inés, Irene Mollinedo-Gajate, J. Javier Meana, et al.. (2018). Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway. Neuropsychopharmacology. 43(10). 2028–2035. 57 indexed citations

10.

Dı́ez-Alarcia, Rebeca, Inés Ibarra‐Lecue, Angela Patricia López‐Cardona, et al.. (2016). Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex. Frontiers in Pharmacology. 7. 415–415. 62 indexed citations

11.

Prades, Roger, et al.. (2016). The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia. European Neuropsychopharmacology. 27(2). 180–191. 16 indexed citations

12.

Horrillo, Igor, Jorge E. Ortega, Rebeca Dı́ez-Alarcia, Leyre Urigüen, & J. Javier Meana. (2016). Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study. Psychopharmacology. 233(23-24). 3861–3867. 3 indexed citations

13.

Arteaga, Olatz, et al.. (2015). Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats. PLoS ONE. 10(11). e0142424–e0142424. 77 indexed citations

14.

Muguruza, Carolina, Fernando Rodrı́guez, Isabel Rozas, et al.. (2012). Antidepressant-like properties of three new α2-adrenoceptor antagonists. Neuropharmacology. 65. 13–19. 19 indexed citations

15.

Ramos‐Miguel, Alfredo, et al.. (2011). Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment. The International Journal of Neuropsychopharmacology. 15(5). 573–588. 26 indexed citations

16.

Martínez‐Orgado, José, David Fernández‐López, Leyre Urigüen, et al.. (2005). Neuroprotective Effect of <i>L</i>-Arginine in a Newborn Rat Model of Acute Severe Asphyxia. Neonatology. 88(4). 291–298. 2 indexed citations

17.

Oliva, J.M., Leyre Urigüen, Sandra Pérez-Rial, & Jorge Manzanares. (2005). Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain. Neuropharmacology. 49(5). 618–626. 44 indexed citations

18.

Urigüen, Leyre, Fernando Berrendero, Catherine Ledent, Rafaël Maldonado, & Jorge Manzanares. (2005). κ‐ and δ‐opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB₁receptor knockout mice. European Journal of Neuroscience. 22(8). 2106–2110. 21 indexed citations

19.

Pérez‐Molina, José A., Juan C. Leza, Marı́a A. Moro, et al.. (2002). Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies. Neuroscience Letters. 333(2). 151–153. 12 indexed citations

20.

Romero, Eva, Beatriz Martín‐Fernández, Onintza Sagredo, et al.. (2002). Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats. Developmental Brain Research. 136(2). 85–92. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact